|
|
Gene Symbol |
APOA1 |
|
Aliases |
HPALP2, apo(a) |
|
Entrez Gene ID |
|
|
Gene Name |
Apolipoprotein A1 |
|
Chromosomal Location |
11q23.3 |
|
HGNC ID |
|
|
Summary |
This gene encodes apolipoprotein A-I, which is the major protein component of high density lipoprotein (HDL) in plasma. The encoded preproprotein is proteolytically processed to generate the mature protein, which promotes cholesterol efflux from tissues to the liver for excretion, and is a cofactor for lecithin cholesterolacyltransferase (LCAT), an enzyme responsible for the formation of most plasma cholesteryl esters. This gene is closely linked with two other apolipoprotein genes on chromosome 11. Defects in this gene are associated with HDL deficiencies, including Tangier disease, and with systemic non-neuropathic amyloidosis. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein. [provided by RefSeq, Dec 2015]
|
|
RefSeq DNA |
|
|
RefSeq mRNA |
|
|
e!Ensembl
|
Gene Ontology (GO)
GO ID |
Ontology |
Function |
Evidence |
Reference |
GO:0002740 |
Biological process |
Negative regulation of cytokine secretion involved in immune response |
IDA |
12458630 |
GO:0006656 |
Biological process |
Phosphatidylcholine biosynthetic process |
IDA |
4335615 |
GO:0006695 |
Biological process |
Cholesterol biosynthetic process |
IBA |
21873635 |
GO:0007179 |
Biological process |
Transforming growth factor beta receptor signaling pathway |
IDA |
23726972 |
GO:0007186 |
Biological process |
G protein-coupled receptor signaling pathway |
IDA |
16443932 |
GO:0007229 |
Biological process |
Integrin-mediated signaling pathway |
IDA |
23726972 |
GO:0008203 |
Biological process |
Cholesterol metabolic process |
IMP |
15464323 |
GO:0010804 |
Biological process |
Negative regulation of tumor necrosis factor-mediated signaling pathway |
IDA |
21571275 |
GO:0010873 |
Biological process |
Positive regulation of cholesterol esterification |
IBA |
21873635 |
GO:0010873 |
Biological process |
Positive regulation of cholesterol esterification |
IDA |
4335615 |
GO:0010875 |
Biological process |
Positive regulation of cholesterol efflux |
IDA |
27472885 |
GO:0010903 |
Biological process |
Negative regulation of very-low-density lipoprotein particle remodeling |
IDA |
14967812 |
GO:0018158 |
Biological process |
Protein oxidation |
IDA |
12576517 |
GO:0018206 |
Biological process |
Peptidyl-methionine modification |
IDA |
12576517 |
GO:0019433 |
Biological process |
Triglyceride catabolic process |
IBA |
21873635 |
GO:0030301 |
Biological process |
Cholesterol transport |
IDA |
10559507 |
GO:0032374 |
Biological process |
Regulation of cholesterol transport |
IBA |
21873635 |
GO:0032489 |
Biological process |
Regulation of Cdc42 protein signal transduction |
IDA |
16443932 |
GO:0033344 |
Biological process |
Cholesterol efflux |
IBA |
21873635 |
GO:0033344 |
Biological process |
Cholesterol efflux |
IDA |
11162594, 14703508, 15358760, 16443932, 21481393 |
GO:0033344 |
Biological process |
Cholesterol efflux |
IMP |
12202492 |
GO:0033700 |
Biological process |
Phospholipid efflux |
IBA |
21873635 |
GO:0033700 |
Biological process |
Phospholipid efflux |
IDA |
11162594, 14703508 |
GO:0034115 |
Biological process |
Negative regulation of heterotypic cell-cell adhesion |
IDA |
21571275 |
GO:0034372 |
Biological process |
Very-low-density lipoprotein particle remodeling |
IBA |
21873635 |
GO:0034375 |
Biological process |
High-density lipoprotein particle remodeling |
IC |
4335615 |
GO:0034375 |
Biological process |
High-density lipoprotein particle remodeling |
IDA |
21481393 |
GO:0034380 |
Biological process |
High-density lipoprotein particle assembly |
IBA |
21873635 |
GO:0034380 |
Biological process |
High-density lipoprotein particle assembly |
IDA |
190223 |
GO:0034384 |
Biological process |
High-density lipoprotein particle clearance |
IC |
12651854 |
GO:0035025 |
Biological process |
Positive regulation of Rho protein signal transduction |
IDA |
23726972 |
GO:0042157 |
Biological process |
Lipoprotein metabolic process |
IBA |
21873635 |
GO:0042632 |
Biological process |
Cholesterol homeostasis |
IBA |
21873635 |
GO:0042632 |
Biological process |
Cholesterol homeostasis |
IDA |
21571275 |
GO:0042632 |
Biological process |
Cholesterol homeostasis |
IMP |
15464323 |
GO:0043691 |
Biological process |
Reverse cholesterol transport |
IBA |
21873635 |
GO:0043691 |
Biological process |
Reverse cholesterol transport |
IMP |
15464323 |
GO:0046889 |
Biological process |
Positive regulation of lipid biosynthetic process |
IBA |
21873635 |
GO:0050713 |
Biological process |
Negative regulation of interleukin-1 beta secretion |
IDA |
12458630 |
GO:0050728 |
Biological process |
Negative regulation of inflammatory response |
IDA |
21571275 |
GO:0050766 |
Biological process |
Positive regulation of phagocytosis |
IDA |
20495215 |
GO:0050821 |
Biological process |
Protein stabilization |
IDA |
17655203, 20495215 |
GO:0050919 |
Biological process |
Negative chemotaxis |
IDA |
23726972 |
GO:0051180 |
Biological process |
Vitamin transport |
IMP |
15140193 |
GO:0051345 |
Biological process |
Positive regulation of hydrolase activity |
IDA |
7638166 |
GO:0051496 |
Biological process |
Positive regulation of stress fiber assembly |
IDA |
23726972 |
GO:0055091 |
Biological process |
Phospholipid homeostasis |
IDA |
21571275 |
GO:0060354 |
Biological process |
Negative regulation of cell adhesion molecule production |
IDA |
21571275 |
GO:0060761 |
Biological process |
Negative regulation of response to cytokine stimulus |
IDA |
21571275 |
GO:0070328 |
Biological process |
Triglyceride homeostasis |
IDA |
21571275 |
GO:0070371 |
Biological process |
ERK1 and ERK2 cascade |
IDA |
23726972 |
GO:0070508 |
Biological process |
Cholesterol import |
IMP |
14718538 |
GO:1900026 |
Biological process |
Positive regulation of substrate adhesion-dependent cell spreading |
IDA |
23726972 |
GO:1902995 |
Biological process |
Positive regulation of phospholipid efflux |
IDA |
27472885 |
GO:0005576 |
Cellular component |
Extracellular region |
HDA |
27068509 |
GO:0005615 |
Cellular component |
Extracellular space |
HDA |
16502470, 20551380, 22664934 |
GO:0005615 |
Cellular component |
Extracellular space |
IDA |
19433579 |
GO:0005615 |
Cellular component |
Extracellular space |
ISS |
22261194 |
GO:0030139 |
Cellular component |
Endocytic vesicle |
IDA |
14747463 |
GO:0031410 |
Cellular component |
Cytoplasmic vesicle |
IDA |
14703508 |
GO:0034361 |
Cellular component |
Very-low-density lipoprotein particle |
IDA |
17154273 |
GO:0034364 |
Cellular component |
High-density lipoprotein particle |
IBA |
21873635 |
GO:0034364 |
Cellular component |
High-density lipoprotein particle |
IDA |
210174, 3104518, 9211985, 15464323, 21571275 |
GO:0034364 |
Cellular component |
High-density lipoprotein particle |
TAS |
27477018 |
GO:0034366 |
Cellular component |
Spherical high-density lipoprotein particle |
IDA |
16682745 |
GO:0042627 |
Cellular component |
Chylomicron |
IBA |
21873635 |
GO:0062023 |
Cellular component |
Collagen-containing extracellular matrix |
HDA |
27559042 |
GO:0070062 |
Cellular component |
Extracellular exosome |
HDA |
19056867, 19199708, 23533145 |
GO:0072562 |
Cellular component |
Blood microparticle |
HDA |
22516433 |
GO:1903561 |
Cellular component |
Extracellular vesicle |
HDA |
24769233 |
GO:0001540 |
Molecular function |
Amyloid-beta binding |
IDA |
11297421 |
GO:0001540 |
Molecular function |
Amyloid-beta binding |
IPI |
9211985 |
GO:0005102 |
Molecular function |
Signaling receptor binding |
IPI |
27477018 |
GO:0005515 |
Molecular function |
Protein binding |
IPI |
1587806, 11297421, 11991719, 12084722, 12917409, 15174051, 17676061, 17786215, 19758344, 25241761, 25416956, 25910212 |
GO:0005543 |
Molecular function |
Phospholipid binding |
IBA |
21873635 |
GO:0005543 |
Molecular function |
Phospholipid binding |
IDA |
12810715 |
GO:0015485 |
Molecular function |
Cholesterol binding |
IBA |
21873635 |
GO:0015485 |
Molecular function |
Cholesterol binding |
IDA |
15464323 |
GO:0019899 |
Molecular function |
Enzyme binding |
IPI |
1587806 |
GO:0031072 |
Molecular function |
Heat shock protein binding |
IPI |
11027668 |
GO:0034190 |
Molecular function |
Apolipoprotein receptor binding |
IPI |
11162594 |
GO:0034191 |
Molecular function |
Apolipoprotein A-I receptor binding |
IPI |
16443932 |
GO:0042802 |
Molecular function |
Identical protein binding |
IPI |
8049247, 17676061, 18719128, 20133843, 22609356, 24316228, 24702826 |
GO:0045499 |
Molecular function |
Chemorepellent activity |
IDA |
23726972 |
GO:0060228 |
Molecular function |
Phosphatidylcholine-sterol O-acyltransferase activator activity |
IBA |
21873635 |
GO:0060228 |
Molecular function |
Phosphatidylcholine-sterol O-acyltransferase activator activity |
IDA |
4335615 |
GO:0070653 |
Molecular function |
High-density lipoprotein particle receptor binding |
IBA |
21873635 |
GO:0070653 |
Molecular function |
High-density lipoprotein particle receptor binding |
IPI |
10764676, 12651854 |
GO:0120020 |
Molecular function |
Intermembrane cholesterol transfer activity |
IBA |
21873635 |
GO:0120020 |
Molecular function |
Intermembrane cholesterol transfer activity |
IDA |
9651324 |
GO:0120020 |
Molecular function |
Intermembrane cholesterol transfer activity |
IMP |
15464323 |
|
Protein Information |
|
Protein Name |
Apolipoprotein A-I, apo-AI, epididymis secretory sperm binding protein |
|
Function |
Participates in the reverse transport of cholesterol from tissues to the liver for excretion by promoting cholesterol efflux from tissues and by acting as a cofactor for the lecithin cholesterol acyltransferase (LCAT). As part of the SPAP complex, activates spermatozoa motility. |
|
|
|
|
|
UniProt |
|
|
PDB |
1AV1, 1GW3, 1GW4, 1ODP, 1ODQ, 1ODR, 2MSC, 2MSD, 2MSE, 2N5E, 3K2S, 3R2P, 4V6M, 6CC9, 6CCH, 6CCX, 6CLZ, 6CM1 |
|
Pfam |
Pfam Accession |
Pfam ID |
PF01442 |
Apolipoprotein |
|
|
|
|
Interactions |
| |
STRING |
MINT |
IntAct |
ENSP00000295228 |
|
P09529 |
|
| |
View interactions
|
|
| |
Associated Diseases
Disease group | Disease Name | References |
Cardiovascular Diseases |
Arteriosclerosis |
|
Hypertensive disease |
|
Diabetic Cardiomyopathies |
|
Digestive System Diseases |
Hepatitis |
|
Liver Diseases |
|
Endocrine System Diseases |
Tangier Disease |
|
PCOS |
|
Immune System Diseases |
Glomerulonephritis |
|
HIV Coinfection |
|
Behcet Syndrome |
|
HIV Infections |
|
Neoplasms |
Stomach Cancer |
|
Adenocarcinoma |
|
Lung Cancer |
|
Carcinoma |
|
Gastric Cancer |
|
Liver Cancer |
|
Cribriform Carcinoma |
|
Nervous System Diseases |
Amyloid Polyneuropathy |
|
Stroke |
|
Nutritional and Metabolic Diseases |
Obesity |
|
Amyloidosis |
|
Ataxia with vitamin E deficiency |
|
Lipid Metabolism Disorders |
|
Psychiatric/Brain disorders |
Obstructive Sleep Apnea |
|
Reproductive disorders |
Preeclampsia |
|
|
References |
|
|
|
PubMed ID |
Associated gene/s |
Associated condition |
Genetic Mutation |
Diagnostic Criteria |
Association with PCOS |
Ethnicity |
Conclusion |
|
APOB |
Dyslipidemia |
|
|
Related
|
|
The study confirms the trend toward dyslipidemia among women with PCOS, particularly in parameters associated with cardiovascular risk. |
|
SHBG |
Cardiovascular risk,obesity, insulin resistance, and hyperandrogenism |
|
Rotterdam criteria |
Related
|
|
PCOS is associated with a more pronounced atherogenic lipid profile. |
|
|
|
|